DanCann Pharma A/S provided revenue guidance for the year 2024. For the year, the company expected to generate approximately DKK 10 million - DKK 11 million in revenue.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0398 DKK | 0.00% | -25.75% | +32.67% |
06-18 | DanCann Pharma A/S Provides Revenue Guidance for the Year 2024 | CI |
06-01 | DanCann Pharma A/S Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+32.67% | 953K | |
+16.44% | 122B | |
+18.94% | 114B | |
+19.62% | 25.71B | |
-25.37% | 19.02B | |
-20.21% | 15.83B | |
-20.20% | 15.32B | |
-47.37% | 14.88B | |
+59.91% | 14.82B | |
+4.35% | 14.1B |
- Stock Market
- Equities
- DANCAN Stock
- News Dancann Pharma A/S
- DanCann Pharma A/S Provides Revenue Guidance for the Year 2024